ID SXMUi001-A AC CVCL_B3RZ SY SXMUi002-A-1; HB-iPSCs; HIPS-F9 DR BioSamples; SAMEA10422684 DR hPSCreg; SXMUi001-A DR Wikidata; Q110433273 RX Patent=CN113881637B; RX PubMed=35121195; CC Group: Patented cell line. CC From: Shanxi Medical University; Taiyuan; China. CC Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.22359. CC Sequence variation: Mutation; HGNC; HGNC:3551; F9; Simple; p.Arg75Ter (c.223C>T); ClinVar=VCV000010572; Zygosity=Hemizygous (Patent=CN113881637B; PubMed=35121195). CC Derived from site: In situ; Urine; UBERON=UBERON_0001088. ST Source(s): Patent=CN113881637B; PubMed=35121195 ST Amelogenin: X,Y ST CSF1PO: 11,12 ST D12S391: 19 ST D13S317: 9,10 ST D16S539: 9,11 ST D18S51: 15,16 ST D19S433: 13 ST D1S1656: 14,17 ST D21S11: 28,31.2 ST D2S1338: 23,35 ST D3S1358: 15,16 ST D5S818: 10,12 ST D6S1043: 12,17 ST D7S820: 11 ST D8S1179: 12,16 ST FGA: 19,23 ST Penta D: 9 ST Penta E: 17,18 ST TH01: 9,9.3 ST TPOX: 9,11 ST vWA: 16 DI NCIt; C26721; Hemophilia B DI ORDO; Orphanet_98879; Hemophilia B OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG Age unspecified CA Induced pluripotent stem cell DT Created: 16-12-21; Last updated: 10-04-25; Version: 6 // RX Patent=CN113881637B; RA Wang, Gang RA Yang, Lin-Hua RA Ma, Yan-Chun RA Yao, Ming-Ze RA Wu, Chang-Xin RA Liu, Xiu-E RA Ren, Juan RA Zhang, Rui-Juan RA Zhang, Xia-Lin RA Sun, Wen-Wen RA Zhao, Li-Dong RT "Human induced pluripotent stem cell and preparation method and RT application thereof."; RL Patent number CN113881637B, 07-Nov-2023. // RX PubMed=35121195; DOI=10.1016/j.scr.2022.102684; RA Ma, Yan-Chun RA Sun, Wen-Wen RA Liu, Xiu-E RA Ren, Juan RA Zhang, Xia-Lin RA Zhang, Rui-Juan RA Zhao, Li-Dong RA Yang, Lin-Hua RA Wang, Gang RT "Generation an induced pluripotent stem cell line SXMUi001-A derived RT from a hemophilia B patient carries variant F9 c.223C>T(p.R75X)."; RL Stem Cell Res. 60:102684-102684(2022). //